Institutional investors purchased a net $133.5 thousand shares of ABIO during the quarter ended June 2016 and now own 52.64% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
AVEO CAPITAL PARTNERS LLC Bought 231.8 Thousand shares of ARCA Biopharma Inc
APO ASSET MANAGEMENT GMBH Bought 17.6 Thousand shares of ARCA Biopharma Inc
MEDICAL STRATEGY GMBH Bought 6.0 Thousand shares of ARCA Biopharma Inc